Boss of Open Orphan volunteers for Covid-19 drug trial
Executive chairman of the Irish drug testing firm, Cathal Friel, wants to be part of study which involves being infected by the virus
The head of Open Orphan, the Irish drug trials and testing company, has said he has volunteered to be infected with a dose of Covid-19 as part of a human study into the virus.
Open Orphan’s subsidiary hVIVO won a £40 million (€44 million) contract with the British government last week which will see it conduct what is termed a human challenge trial, that will involve volunteers being given a strain of Covid-19 to study...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
Average salary at Google’s Dublin HQ rises to €108,000
New accounts show turnover at the tech giant’s Irish operation increased from €38.1 billion in 2018 to €45.7 billion in 2019
Covid-19 takes huge bite out of Greencore’s British sales
Analysis: The sandwich-maker has tapped its shareholders for €100 million amid the continuing uncertainty over the pandemic
UDG Healthcare’s Sharp division outperforms its chief executive’s hopes
The contract clinical, manufacturing, packaging and technology services business sees 34 per cent increase in adjusted operating profit